Revenue Breakdown
Composition ()
No data
Revenue Streams
Artivion Inc (AORT) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Aortic stent grafts, accounting for 34.9% of total sales, equivalent to $39.59M. Other significant revenue streams include On X and Preservation Services. Understanding this composition is critical for investors evaluating how AORT navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Artivion Inc maintains a gross margin of 65.61%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.26%, while the net margin is 5.73%. These profitability ratios, combined with a Return on Equity (ROE) of -2.45%, provide a clear picture of how effectively AORT converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, AORT competes directly with industry leaders such as LMAT and ESTA. With a market capitalization of $1.88B, it holds a significant position in the sector. When comparing efficiency, AORT's gross margin of 65.61% stands against LMAT's 75.28% and ESTA's 70.09%. Such benchmarking helps identify whether Artivion Inc is trading at a premium or discount relative to its financial performance.
